Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Fever × Dermatologic × Clear all

Phase

Status

Sponsor Class

NETWORK 3 OTHER 1 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4 Classical hematology 2 Thoracic 1 Sarcoma 1 Myeloid 1 Lymphoid 1 Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Melanoma 975 Carcinoma, Non-Small-Cell Lung 245 Neoplasms 176 Keratosis, Actinic 166 Carcinoma, Renal Cell 143 Skin Neoplasms 128 Colorectal Neoplasms 121 Neoplasm Metastasis 120 Squamous Cell Carcinoma of Head and Neck 117 Ovarian Neoplasms 99 Breast Neoplasms 97 Carcinoma, Basal Cell 85 Stomach Neoplasms 80 Lymphoma, T-Cell, Cutaneous 79 Head and Neck Neoplasms 79 Pancreatic Neoplasms 77 Lung Neoplasms 77 Triple Negative Breast Neoplasms 67 Uterine Cervical Neoplasms 62 Carcinoma, Hepatocellular 60 Sarcoma 57 Carcinoma, Merkel Cell 56 Uveal Melanoma 55 Urinary Bladder Neoplasms 55 Prostatic Neoplasms 53 Esophageal Neoplasms 52 Lymphoma 50 Endometrial Neoplasms 48 Small Cell Lung Carcinoma 47 Carcinoma, Transitional Cell 47

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03551626 2025-04-29

COMBI-APlus

Novartis

Phase 3 Completed

552 enrolled 12 charts

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡